**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 10099-74-8 |Lead Nitrate | >99 | 233-245-9 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T
Risk Phrases: 20/22 33 61 62
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation and if swallowed. Danger of cumulative
effects. May cause harm to the unborn child. Possible risk of
impaired fertility.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May cause effects similar to those for inhalation
exposure.
Inhalation:
May cause methemoglobinemia, cyanosis, convulsions, tachycardia,
dyspnea (labored breathing), and death. May cause adverse central
nervous system effects including headache, convulsions, and possible
death. May cause kidney damage. May cause anemia.
Chronic:
Chronic inhalation and ingestion may cause effects similar to those
of acute inhalation and ingestion. Prolonged or repeated exposure
may cause adverse reproductive effects. May cause liver and kidney
damage. Prolonged exposure may cause anemia and methemoglobinemia,
characterized by dizziness, drowsiness, headache, breath shortness,
cyanosis (bluish skin due to deficient oxygenation of the blood),
rapid heart rate and chocolate-brown colored blood. Chronic exposure
to lead may result in plumbism which is characterized by lead line in
gum, headache, muscle weakness, mental changes.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of soap and water for at
least 15 minutes while removing contaminated clothing and shoes. Wash
clothing before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Remove from exposure to fresh air immediately. If not breathing,
give artificial respiration. If breathing is difficult, give oxygen.
Get medical aid.
Notes to Physician:
Antidote:
The use of Calcium disodium EDTA as a chelating agent should be
determined by qualified medical personnel. The use of
d-Penicillamine as a chelating agent should be determined by
qualified medical personnel. The use of Dimercaprol or BAL (British
Anti-Lewisite) as a chelating agent should be determined by qualified
medical personnel.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Combustion generates toxic fumes. Oxidizer. Greatly
increases the burning rate of combustible materials.
Extinguishing Media:
Use water only!
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use only in a well-ventilated area. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Keep container tightly closed. Avoid ingestion and
inhalation. Keep away from clothing and other combustible materials.
Storage:
Do not store near combustible materials. Store in a tightly closed
container. Store in a cool, dry, well-ventilated area away from
incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29CFR
1910.134 or European Standard EN 149. Always use a
NIOSH or European Standard EN 149 approved respirator
when necessary.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Appearance: white
Odor: None reported.
pH: Not available.
Vapor Pressure: Negligible.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 470 deg C dec
Autoignition Temperature: Not available.
Flash Point: 290 deg C ( 554.00 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: 290 deg C
Solubility in water: 1g/2.5l absolute alcohol, 1g/75ml methan
Specific Gravity/Density: 4.5300g/cm3
Molecular Formula: PbN2O6
Molecular Weight: 331.20
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures. Decomposes when
heated.
Conditions to Avoid:
Incompatible materials, combustible materials, temperatures above
200C.
Incompatibilities with Other Materials:
Forms an explosive compound with: ammonium thiocyanate, potassium
acetate, or lead hypophosphite. Other incompatibles include:
aluminum, alkyl esters, carbon, hydroxylamine, phosphorus,
phosphinates, sulfur, tin chloride.
Hazardous Decomposition Products:
Nitrogen oxides, lead/lead oxides.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 10099-74-8: OG2100000
LD50/LC50:
Not available.
Carcinogenicity:
Lead Nitrate -
ACGIH: A3 - Animal Carcinogen (as Pb) (listed as ** undefined **)
California: carcinogen; initial date 10/1/92 (listed as ** undefined *
OSHA: Possible select carcinogen (listed as ** undefined **).
IARC: Group 2B carcinogen (listed as ** undefined **).
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: LEAD NITRATE
Hazard Class: 5.1
UN Number: 1469
Packing Group: II
IMO
Shipping Name: LEAD NITRATE
Hazard Class: 5.1
UN Number: 1469
Packing Group: II
RID/ADR
Shipping Name: LEAD NITRATE
Dangerous Goods Code: 5.1(29B)
UN Number: 1469
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 20/22 Harmful by inhalation and if swallowed.
R 33 Danger of cumulative effects.
R 61 May cause harm to the unborn child.
R 62 Possible risk of impaired fertility.
Safety Phrases:
S 53 Avoid exposure - obtain special instructions
before use.
S 13 Keep away from food, drink and animal feeding
stuffs.
S 20/21 When using do not eat, drink or smoke.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 10099-74-8: 2
United Kingdom Occupational Exposure Limits
Canada
CAS# 10099-74-8 is listed on Canada's DSL List.
CAS# 10099-74-8 is listed on Canada's Ingredient Disclosure List.
Exposure Limits
CAS# 10099-74-8: OEL-ARAB Republic of Egypt:TWA 0.05 mg(Pb)/m3
OEL-AUSTRALIA:TWA 0.15 mg(Pb)/m3
OEL-AUSTRIA:TWA 0.1 mg(Pb)/m3
OEL-BELGIUM:TWA 0.15 mg(Pb)/m3
OEL-DENMARK:TWA 0.1 mg(Pb)/m3
OEL-FINLAND:TWA 0.1 mg(Pb)/m3
OEL-FRANCE:TWA 0.15 mg(Pb)/m3
OEL-GERMANY:TWA 0.1 mg(Pb)/m3
OEL-HUNGARY:STEL 0.04 mg(Pb)/m3;Carcinogen
OEL-THE PHILIPPINES:TWA 0.15 mg(Pb)/m3
OEL-RUSSIA:STEL 0.005 ppm (0.01 mg(Pb)/m3)
OEL-SWEDEN:TWA 0.05 mg(Pb)/m3 (resp. dust)
OEL-SWEDEN:TWA 0.1 mg(Pb)/m3 (total dust)
OEL-SWITZERLAND:TWA 0.1 mg(Pb)/m3
OEL-THAILAND:TWA 0.2 mg(Pb)/m3
OEL-TURKEY:TWA 0.2 mg(Pb)/m3
OEL-UNITED KINGDOM:TWA 0.15 mg(Pb)/m3
OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV
OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGI TLV
US FEDERAL
TSCA
CAS# 10099-74-8 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 7/06/1998 Revision #1 Date: 8/02/2000
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Nalpha-BOC-D-ASPARAGINE, 98%
| 75647-01-7 |
|
3-Methyl-1-butanol
| 123-51-3 |
|
N-alpha-BOC-D-Glutamine, 98%
| 61348-28-5 |
|
N-Octyl isothiocyanate
| 4430-45-9 |
|
NALPHA-BOC-D-HISTIDINE, 98%
| 50654-94-9 |
|
1,6-Hexanediamine, 60 wt % Aqueous Soln.
| 124-09-4 |
|
Isopropyl Ether
| 108-20-3 |
|
L-Alanine
| 56-41-7 |
|
alpha-Ketoglutaric Acid
| 328-50-7 |
|
L-(+)-Lysine Monohydrochloride, 99+%
| 657-27-2 |
|
BOC-D-Leucine monohydrate, 98%
| 16937-99-8 |
|
l-(+)-Glutamine, 99%
| 56-85-9 |
|
l-(+)-Arginine hydrochloride, 98+%
| 1119-34-2 |
|
l-Valine, 97% (titr.)
| 72-18-4 |
|
L-Cystine, 96% (titr.)
| 56-89-3 |
|
L-(+)-Arginine, 98+%
| 74-79-3 |
|
BOC-D-Methionine, 98%
| 5241-66-7 |
|
BOC-L-Norleucine, 98%
| 6404-28-0 |
|
BOC-L-Norvaline, 98%
| 53308-95-5 |
|
BOC-D-Proline, 98%
| 37784-17-1 |
|
l(+)-Ascorbic acid, reagent acs
| 50-81-7 |
|
L(+)-Asparagine Monohydrate, 99%
| 5794-13-8 |
|
3'-Bromopropiophenone, 98%
| 19829-98-8 |
|
Lead Nitrate, Reagent ACS (Crystals)
| 10099-74-8 |
|
L-Aspartic acid-4-(4-methyl-7-coumarinylamide)
| 133628-73-6 |
|
1-(4-Fluorophenyl)piperazine, 98%
| 2252-63-3 |
|
Lead(II) oxide, 99.7%
| 1317-36-8 |
|
Lecithin, granular
| 8002-43-5 |
|
Light Green SF, Yellowish (Cert)
| 5141-20-8 |
|
5-Bromo-6-Chloro-3-Indolyl-beta-D-Glucuronide Cyclohexylammonium Salt
| 144110-43-0 |
|
4-Nitrophenyl-N-Acetyl-??-D-Galactosaminide
| 14948-96-0 |
|
Phenyl-beta-D-Glucuronide Hydrate, 99%
| 17685-05-1 |
|
4-Methylumbelliferyl-alpha-D-Mannopyranoside Hydrate, 99%
| 28541-83-5 |
|
alpha-Terpineol
| 98-55-5 |
|
Ligroine, boiling range 35 - 60 degree C
| 8032-32-4 |
|
Lithium Bromide, 99.999%
| 7550-35-8 |
|
Phenylmagnesium chloride, 25 wt% solution in tetrahydrofuran
| 100-59-4 |
|
1-Hydroxy-9-fluorenone, 99%
| 6344-60-1 |
|
Zinc Sulfide
| 1314-98-3 |
|
Lithium Carbonate, 99%
| 554-13-2 |
|
3-Indoxyl Phosphate Disodium Salt, 99%
| 3318-43-2 |
|
Magnesium Oxide, P.A.
| 1309-48-4 |
|
6,7-Diethoxy-1-phenyl-1,2,3,4-tetrahydroisoquinoline hydrochloride,
| 94914-42-8 |
|
Magnesium perchlorate, reagent ACS
| 10034-81-8 |
|
Magnesium Sulfate, Anhydrous, 97% (titr.)
| 7487-88-9 |
|
Magnesium sulfate heptahydrate, p.a
| 7487-88-9 |
|
n-Pentyl propionate, 99+%
| 624-54-4 |
|
Maleic Acid, 99%
| 110-16-7 |
|
Malonic acid, 99%
| 141-82-2 |
|
2-Methyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride,
| 16135-43-6 |
|
|